J
Jean-Yves Reginster
Researcher at University of Liège
Publications - 1231
Citations - 67113
Jean-Yves Reginster is an academic researcher from University of Liège. The author has contributed to research in topics: Osteoporosis & Strontium ranelate. The author has an hindex of 110, co-authored 1195 publications receiving 58146 citations. Previous affiliations of Jean-Yves Reginster include HEC Paris & World Health Organization.
Papers
More filters
Journal ArticleDOI
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Robert M. Neer,Claude D. Arnaud,Jose R. Zanchetta,Richard L. Prince,Gregory A Gaich,Jean-Yves Reginster,Anthony B. Hodsman,Erik Fink Eriksen,Sophia Ish-Shalom,Harry K. Genant,Ouhong Wang,Bruce H. Mitlak +11 more
TL;DR: Treatment of postmenopausal osteoporosis with parathyroid hormone decreases the risk of vertebral and nonvertebral fractures; increases vertebral, femoral, and total-body bone mineral density; and is well tolerated.
Journal ArticleDOI
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
John A. Kanis,Eugene V. McCloskey,Helena Johansson,Cyrus Cooper,René Rizzoli,Jean-Yves Reginster +5 more
TL;DR: In this paper, the European Foundation for Osteoporosis and Bone disease (subsequently the International osteopo- rosis Foundation) published guidelines for the diagnosis and management of osteoporrosis in a European setting.
Journal ArticleDOI
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
Michael R. McClung,Piet Geusens,Paul D. Miller,Hartmut Zippel,William G. Bensen,Christian Roux,Silvano Adami,Ignac Fogelman,Terrence H. Diamond,Richard Eastell,Pierre J. Meunier,Richard D. Wasnich,Maria Greenwald,Jean-Marc Kaufman,C Chesnut,Jean-Yves Reginster +15 more
TL;DR: In this paper, the authors found that risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known, and the women were randomly assigned to receive treatment with either oral risingronate (2.5 or 5.0 mg) or placebo for three years.
Journal ArticleDOI
Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature.
TL;DR: Overall, total hip and total knee arthroplasties were found to be quite effective in terms of improvement in health-related quality-of-life dimensions, with the occasional exception of the social dimension.
Journal ArticleDOI
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
Pierre J. Meunier,Christian Roux,Ego Seeman,Sergio Ortolani,J. Badurski,Tim D. Spector,J. Cannata,Adam Balogh,EM Lemmel,S. Pors-Nielsen,René Rizzoli,Harry K. Genant,Jean-Yves Reginster +12 more
TL;DR: Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures.